Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/25/25 → … |
Liposomal irinotecan (nal-IRI) plus 5-fluorouracil and leucovorin (5-FU/LV) plus oxaliplatin (NALIRIFOX) as First-Line Chemotherapy for Patients with Advanced Small Intestine and Appendiceal Cancers
- Abdelrahim, Maen (PI)
- Esmail, Abdullah (Key Personnel)
- Mathur, Sunil (Key Personnel)
Project: Clinical Trial